Literature DB >> 2953500

A randomized double-blind comparison of fentanyl and sufentanil anaesthesia for coronary artery surgery.

I R Thomson, R J Hudson, M Rosenbloom, R C Meatherall.   

Abstract

Using a randomized double-blind protocol the authors compared two narcotic anaesthetic regimens in 33 patients with good ventricular function undergoing coronary artery surgery. After premedication with morphine and scopolamine, patients received either fentanyl 100 micrograms X kg-1 (n = 16), or sufentanil 15 micrograms X kg-1 (n = 17), intravenously (IV) over 10 min to induce anaesthesia. Metocurine 0.42 mg X kg-1 provided muscle relaxation. No further IV anaesthetic agents were given. The haemodynamic response to induction, intubation, and surgery, differed minimally between agents. The degree of rigidity on induction was identical with both agents, as were the intervals following induction at which patients lost consciousness, regained consciousness, or met criteria for extubation. However, the interval until extubation criteria were met did correlate with the duration of cardiopulmonary bypass. Sufentanil 15 micrograms X kg-1, was clinically indistinguishable from fentanyl 100 micrograms X kg-1, when used as the primary anaesthetic agent for coronary surgery.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2953500     DOI: 10.1007/BF03015157

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  10 in total

1.  Neuropsychologic outcome after open-heart surgery.

Authors:  K A Sotaniemi; A Juolasmaa; E T Hokkanen
Journal:  Arch Neurol       Date:  1981-01

2.  Comparison of sufentanil--O2 and fentanyl--02 for coronary artery surgery.

Authors:  S de Lange; M J Boscoe; T H Stanley; N Pace
Journal:  Anesthesiology       Date:  1982-02       Impact factor: 7.892

3.  The pharmacokinetics of sufentanil in surgical patients.

Authors:  J G Bovill; P S Sebel; C L Blackburn; V Oei-Lim; J J Heykants
Journal:  Anesthesiology       Date:  1984-11       Impact factor: 7.892

4.  Effect of cardiopulmonary bypass on fentanyl distribution and elimination.

Authors:  A J Koska; A Romagnoli; W G Kramer
Journal:  Clin Pharmacol Ther       Date:  1981-01       Impact factor: 6.875

5.  A comparison of fentanyl-O2 and sufentanil-O2 for cardiac anesthesia.

Authors:  M B Howie; T D McSweeney; R P Lingam; S P Maschke
Journal:  Anesth Analg       Date:  1985-09       Impact factor: 5.108

6.  Narcotic requirements for intravenous anesthesia.

Authors:  J E Wynands; P Wong; G E Townsend; J S Sprigge; D G Whalley
Journal:  Anesth Analg       Date:  1984-02       Impact factor: 5.108

7.  A comparison of morphine, fentanyl, and sufentanil anesthesia for cardiac surgery: induction, emergence, and extubation.

Authors:  T J Sanford; N T Smith; H Dec-Silver; W K Harrison
Journal:  Anesth Analg       Date:  1986-03       Impact factor: 5.108

Review 8.  Opioid analgesics in anesthesia: with special reference to their use in cardiovascular anesthesia.

Authors:  J G Bovill; P S Sebel; T H Stanley
Journal:  Anesthesiology       Date:  1984-12       Impact factor: 7.892

9.  Intravenous fentanyl kinetics.

Authors:  D A McClain; C C Hug
Journal:  Clin Pharmacol Ther       Date:  1980-07       Impact factor: 6.875

10.  Pharmacokinetics of fentanyl in patients undergoing abdominal aortic surgery.

Authors:  R J Hudson; I R Thomson; J E Cannon; R M Friesen; R C Meatherall
Journal:  Anesthesiology       Date:  1986-03       Impact factor: 7.892

  10 in total
  5 in total

1.  Anesthetic considerations in acute myocardial infarction.

Authors:  S Slogoff
Journal:  Tex Heart Inst J       Date:  1991

Review 2.  Sufentanil. A review of its pharmacological properties and therapeutic use.

Authors:  J P Monk; R Beresford; A Ward
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

3.  Haemodynamic interactions of muscle relaxants and sufentanil in coronary artery surgery.

Authors:  D Côté; R Martin; J P Tétrault
Journal:  Can J Anaesth       Date:  1991-04       Impact factor: 5.063

4.  Are "clean" muscle relaxants better?

Authors:  I R Thomson
Journal:  Can J Anaesth       Date:  1994-06       Impact factor: 5.063

5.  The efficacy and safety of a pharmacologic protocol for maintaining coronary artery bypass patients at a higher mean arterial pressure during cardiopulmonary bypass. 1998.

Authors:  P A Pirraglia; J C Peterson; G S Hartman; F S Yao; S J Thomas; M E Charlson
Journal:  J Extra Corpor Technol       Date:  2013-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.